Antiproteinuric effects of cilnidipine.
Staessen
J A
JA
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004095:Dihydropyridines / Q000627:therapeutic use*; D006801:Humans; D011507:Proteinuria / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000592:standards
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; C065927:cilnidipine